These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 20627670)

  • 41. Drug-induced vanishing bile duct syndrome: response to ursodiol.
    O'Brien CB; Shields DS; Saul SH; Reddy KR
    Am J Gastroenterol; 1996 Jul; 91(7):1456-7. PubMed ID: 8678017
    [No Abstract]   [Full Text] [Related]  

  • 42. Primary biliary cirrhosis: when and why does the disease develop?
    Floreani A; Ostuni PA; Ferrara F; Guido M
    Dig Liver Dis; 2006 Apr; 38(4):272-5. PubMed ID: 16567309
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Clinical studies with silymarin: fibrosis progression is the end point.
    Schuppan D; Hahn EG
    Hepatology; 2001 Feb; 33(2):483-4. PubMed ID: 11172360
    [No Abstract]   [Full Text] [Related]  

  • 44. Reflections on therapeutic trials in primary biliary cirrhosis: a quality of life oriented counter-view.
    Jones DE; Bhala N; Newton JL
    Hepatology; 2006 Mar; 43(3):633; author reply 634. PubMed ID: 16496315
    [No Abstract]   [Full Text] [Related]  

  • 45. Unusual clinical manifestations in a case of Alagille syndrome.
    Gadkari R; Doshi B; Nayak C; Ghildiyal R; Madke B; Ghia D
    Pediatr Dermatol; 2014; 31(5):599-602. PubMed ID: 25333075
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Biochemical markers of liver fibrosis and lymphocytic piecemeal necrosis in UDCA-treated patients with primary biliary cirrhosis.
    Corpechot C; Poujol-Robert A; Wendum D; Galotte M; Chrétien Y; Poupon RE; Poupon R
    Liver Int; 2004 Jun; 24(3):187-93. PubMed ID: 15189267
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Ursodeoxycholic acid after liver transplantation: does conjugation with taurine make the difference?
    Beuers U
    Ital J Gastroenterol Hepatol; 1999; 31(6):469-71. PubMed ID: 10575564
    [No Abstract]   [Full Text] [Related]  

  • 48. Non-alcoholic steato-hepatitis.
    Chawla Y; Amrapurkar D
    Trop Gastroenterol; 2002; 23(4):186-8. PubMed ID: 12833707
    [No Abstract]   [Full Text] [Related]  

  • 49. Natural history of primary biliary cirrhosis.
    Mayo MJ
    Clin Liver Dis; 2008 May; 12(2):277-88; viii. PubMed ID: 18456180
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Primary biliary cirrhosis.
    Kaplan MM; Gershwin ME
    N Engl J Med; 2005 Sep; 353(12):1261-73. PubMed ID: 16177252
    [No Abstract]   [Full Text] [Related]  

  • 51. Hepatic fibrosis - therapeutic strategies.
    Schuppan D; Strobel D; Hahn EG
    Digestion; 1998; 59(4):385-90. PubMed ID: 9693214
    [No Abstract]   [Full Text] [Related]  

  • 52. Ursodesoxycholic acid: effect on xanthomas in Alagille-Watson syndrome.
    Krawinkel MB; Santer R; Oldigs HD
    J Pediatr Gastroenterol Nutr; 1994 Nov; 19(4):476-7. PubMed ID: 7877009
    [No Abstract]   [Full Text] [Related]  

  • 53. Long-term ursodeoxycholic acid therapy for primary biliary cirrhosis: a follow-up to 12 years.
    Chan CW; Gunsar F; Feudjo M; Rigamonti C; Vlachogiannakos J; Carpenter JR; Burroughs AK
    Aliment Pharmacol Ther; 2005 Feb; 21(3):217-26. PubMed ID: 15691295
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Beta-carotene-induced hepatic fibrosis.
    Graffin B; Genty I; Crétel E; Jean R; Durand JM
    Dig Dis Sci; 2002 Apr; 47(4):793. PubMed ID: 11991611
    [No Abstract]   [Full Text] [Related]  

  • 55. Alagille syndrome: experience of a tertiary care center in North India.
    Srivastava A; Goel D; Bolia R; Poddar U; Yachha SK
    Indian J Gastroenterol; 2014 Jan; 33(1):59-62. PubMed ID: 24222371
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Posterior embryotoxon confirming the phenotypic-genotypic relationship in a case of Alagille syndrome].
    Mairot K; Gonzalves M; Ho Wang Yin G; Denis D
    J Fr Ophtalmol; 2019 Dec; 42(10):e453-e454. PubMed ID: 31377001
    [No Abstract]   [Full Text] [Related]  

  • 57. Adolescent with systemic disease and diagnostic corneal opacification. Posterior embryotoxon associated with Alagille syndrome.
    Yeung HH
    J Pediatr Ophthalmol Strabismus; 2012; 49(3):137-8, 144. PubMed ID: 22589141
    [No Abstract]   [Full Text] [Related]  

  • 58. Globi pallidi injury not caused by manganese in cirrhosis of Alagille syndrome.
    Nagai Y; Hayakawa I; Tsutsumi Y; Kasahara M; Abe Y
    Pediatr Int; 2022 Jan; 64(1):e15088. PubMed ID: 35396816
    [No Abstract]   [Full Text] [Related]  

  • 59. Alagille syndrome and other hereditary causes of cholestasis.
    Hartley JL; Gissen P; Kelly DA
    Clin Liver Dis; 2013 May; 17(2):279-300. PubMed ID: 23540503
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Index of suspicion. Case 1. Alagille syndrome.
    Prescilla R; Lin CH
    Pediatr Rev; 1999 Sep; 20(9):309, 310. PubMed ID: 10473660
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.